目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by End-user
Market segments
Comparison by End-user
Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025
Hospitals and diagnostic centers - Market size and forecast 2020-2025
Academic institutes and research organizations - Market size and forecast 2020-2025
Market opportunity by End-user

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Agilent Technologies Inc.
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
New England Biolabs Inc.
Promega Corp.
QIAGEN NV
Rockland Immunochemicals Inc.
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
Exhibits1: Key Finding 1
Exhibits2: Key Finding 2
Exhibits3: Key Finding 3
Exhibits4: Key Finding 5
Exhibits5: Key Finding 6
Exhibits6: Key Finding 7
Exhibits7: Key Finding 8
Exhibits8: Parent market
Exhibits9: Market characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits14: Five forces analysis 2020 & 2025
Exhibits15: Bargaining power of buyers
Exhibits16: Bargaining power of suppliers
Exhibits17: Threat of new entrants
Exhibits18: Threat of substitutes
Exhibits19: Threat of rivalry
Exhibits20: Market condition - Five forces 2020
Exhibits21: End-user - Market share 2020-2025 (%)
Exhibits22: Comparison by End-user
Exhibits23: Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025 ($ million)
Exhibits24: Biotechnology and pharmaceutical companies - Year-over-year growth 2020-2025 (%)
Exhibits25: Hospitals and diagnostic centers - Market size and forecast 2020-2025 ($ million)
Exhibits26: Hospitals and diagnostic centers - Year-over-year growth 2020-2025 (%)
Exhibits27: Academic institutes and research organizations - Market size and forecast 2020-2025 ($ million)
Exhibits28: Academic institutes and research organizations - Year-over-year growth 2020-2025 (%)
Exhibits29: Market opportunity by End-user
Exhibits30: Customer landscape
Exhibits31: Market share By Geographical Landscape 2020-2025 (%)
Exhibits32: Geographic comparison
Exhibits33: North America - Market size and forecast 2020-2025 ($ million)
Exhibits34: North America - Year-over-year growth 2020-2025 (%)
Exhibits35: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits36: Europe - Year-over-year growth 2020-2025 (%)
Exhibits37: Asia - Market size and forecast 2020-2025 ($ million)
Exhibits38: Asia - Year-over-year growth 2020-2025 (%)
Exhibits39: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits40: ROW - Year-over-year growth 2020-2025 (%)
Exhibits41: Key leading countries
Exhibits42: Market opportunity By Geographical Landscape ($ million)
Exhibits43: Impact of drivers and challenges
Exhibits44: Vendor landscape
Exhibits45: Landscape disruption
Exhibits46: Industry risks
Exhibits47: Vendors covered
Exhibits48: Market positioning of vendors
Exhibits49: Agilent Technologies Inc. - Overview
Exhibits50: Agilent Technologies Inc. - Business segments
Exhibits51: Agilent Technologies Inc. - Key offerings
Exhibits52: Agilent Technologies Inc. - Key customers
Exhibits53: Agilent Technologies Inc. - Segment focus
Exhibits54: F. Hoffmann-La Roche Ltd. - Overview
Exhibits55: F. Hoffmann-La Roche Ltd. - Business segments
Exhibits56: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibits57: F. Hoffmann-La Roche Ltd. - Key customers
Exhibits58: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibits59: Illumina Inc. - Overview
Exhibits60: Illumina Inc. - Product and service
Exhibits61: Illumina Inc. - Key offerings
Exhibits62: Illumina Inc. - Key customers
Exhibits63: Illumina Inc. - Segment focus
Exhibits64: Merck KGaA - Overview
Exhibits65: Merck KGaA - Business segments
Exhibits66: Merck KGaA - Key offerings
Exhibits67: Merck KGaA - Key customers
Exhibits68: Merck KGaA - Segment focus
Exhibits69: New England Biolabs Inc. - Overview
Exhibits70: New England Biolabs Inc. - Product and service
Exhibits71: New England Biolabs Inc. - Key offerings
Exhibits72: New England Biolabs Inc. - Key customers
Exhibits73: New England Biolabs Inc. - Segment focus
Exhibits74: Promega Corp. - Overview
Exhibits75: Promega Corp. - Product and service
Exhibits76: Promega Corp. - Key offerings
Exhibits77: Promega Corp. - Key customers
Exhibits78: Promega Corp. - Segment focus
Exhibits79: QIAGEN NV - Overview
Exhibits80: QIAGEN NV - Business segments
Exhibits81: QIAGEN NV - Key offerings
Exhibits82: QIAGEN NV - Key customers
Exhibits83: QIAGEN NV - Segment focus
Exhibits84: Rockland Immunochemicals Inc.- Overview
Exhibits85: Rockland Immunochemicals Inc.- Product and service
Exhibits86: Rockland Immunochemicals Inc.- Key offerings
Exhibits87: Rockland Immunochemicals Inc.- Key customers
Exhibits88: Rockland Immunochemicals Inc.- Segment focus
Exhibits89: Takara Bio Inc. - Overview
Exhibits90: Takara Bio Inc. - Business segments
Exhibits91: Takara Bio Inc. - Key offerings
Exhibits92: Takara Bio Inc. - Key customers
Exhibits93: Takara Bio Inc. - Segment focus
Exhibits94: Thermo Fisher Scientific Inc. - Overview
Exhibits95: Thermo Fisher Scientific Inc. - Business segments
Exhibits96: Thermo Fisher Scientific Inc. - Key offerings
Exhibits97: Thermo Fisher Scientific Inc. - Key customers
Exhibits98: Thermo Fisher Scientific Inc. - Segment focus
Exhibits99: Currency conversion rates for US$
Exhibits100: Research Methodology
Exhibits101: Validation techniques employed for market sizing
Exhibits102: Information sources
Exhibits103: List of abbreviations